NDC 70518-0400

Clopidogrel

Clopidogrel

Clopidogrel is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Clopidogrel Bisulfate.

Product ID70518-0400_847d093f-a5ab-9d7f-e053-2a91aa0ad547
NDC70518-0400
Product TypeHuman Prescription Drug
Proprietary NameClopidogrel
Generic NameClopidogrel
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2017-04-05
Marketing CategoryANDA / ANDA
Application NumberANDA202928
Labeler NameREMEDYREPACK INC.
Substance NameCLOPIDOGREL BISULFATE
Active Ingredient Strength75 mg/1
Pharm ClassesDecreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 70518-0400-0

90 TABLET in 1 BOTTLE, PLASTIC (70518-0400-0)
Marketing Start Date2017-04-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-0400-0 [70518040000]

Clopidogrel TABLET
Marketing CategoryANDA
Application NumberANDA202928
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-04-05

NDC 70518-0400-1 [70518040001]

Clopidogrel TABLET
Marketing CategoryANDA
Application NumberANDA202928
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-04-14

Drug Details

Active Ingredients

IngredientStrength
CLOPIDOGREL BISULFATE75 mg/1

OpenFDA Data

SPL SET ID:74af0619-5a87-4718-8d30-7e63cf0fbc69
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 309362

    • Pharmacological Class

    • Decreased Platelet Aggregation [PE]
    • P2Y12 Platelet Inhibitor [EPC]
    • P2Y12 Receptor Antagonists [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]